Alnylam Pharmaceuticals (ALNY) PT Raised to $280 at JPMorgan
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $226.62 +1.19%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
JPMorgan analyst Jessica Fye raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $280.00 (from $248.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Asia Vital Components Co Ltd (3017:TT) PT Raised to NT$4,250 at Macquarie
- JPMorgan Downgrades Computershare Limited (CPU:AU) (CMSQY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
